vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Simpson Manufacturing Co., Inc. (SSD). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $588.0M, roughly 1.4× Simpson Manufacturing Co., Inc.). Simpson Manufacturing Co., Inc. runs the higher net margin — 15.0% vs 0.5%, a 14.5% gap on every dollar of revenue. On growth, Simpson Manufacturing Co., Inc. posted the faster year-over-year revenue change (9.1% vs 7.5%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -0.8%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Simpson Manufacturing Company is a leading building materials manufacturer in the United States that produces structural connectors, fasteners, anchors, and products for new construction and retrofitting.
ACHC vs SSD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $588.0M |
| Net Profit | $4.5M | $88.2M |
| Gross Margin | — | 45.2% |
| Operating Margin | — | 19.5% |
| Net Margin | 0.5% | 15.0% |
| Revenue YoY | 7.5% | 9.1% |
| Net Profit YoY | -50.8% | 13.3% |
| EPS (diluted) | $0.05 | $2.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $588.0M | ||
| Q4 25 | $821.5M | $539.3M | ||
| Q3 25 | $851.6M | $623.5M | ||
| Q2 25 | $869.2M | $631.1M | ||
| Q1 25 | $770.5M | $538.9M | ||
| Q4 24 | $774.2M | $517.4M | ||
| Q3 24 | $815.6M | $587.2M | ||
| Q2 24 | $796.0M | $597.0M |
| Q1 26 | $4.5M | $88.2M | ||
| Q4 25 | $-1.2B | $56.2M | ||
| Q3 25 | $36.2M | $107.4M | ||
| Q2 25 | $30.1M | $103.5M | ||
| Q1 25 | $8.4M | $77.9M | ||
| Q4 24 | $32.6M | $55.4M | ||
| Q3 24 | $68.1M | $93.5M | ||
| Q2 24 | $78.5M | $97.8M |
| Q1 26 | — | 45.2% | ||
| Q4 25 | — | 43.4% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.8% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 46.7% |
| Q1 26 | — | 19.5% | ||
| Q4 25 | -142.4% | 13.9% | ||
| Q3 25 | 4.7% | 22.6% | ||
| Q2 25 | 5.8% | 22.2% | ||
| Q1 25 | 1.7% | 19.0% | ||
| Q4 24 | 4.9% | 14.8% | ||
| Q3 24 | 12.1% | 21.3% | ||
| Q2 24 | 13.4% | 22.1% |
| Q1 26 | 0.5% | 15.0% | ||
| Q4 25 | -143.3% | 10.4% | ||
| Q3 25 | 4.3% | 17.2% | ||
| Q2 25 | 3.5% | 16.4% | ||
| Q1 25 | 1.1% | 14.5% | ||
| Q4 24 | 4.2% | 10.7% | ||
| Q3 24 | 8.4% | 15.9% | ||
| Q2 24 | 9.9% | 16.4% |
| Q1 26 | $0.05 | $2.13 | ||
| Q4 25 | $-12.98 | $1.34 | ||
| Q3 25 | $0.40 | $2.58 | ||
| Q2 25 | $0.33 | $2.47 | ||
| Q1 25 | $0.09 | $1.85 | ||
| Q4 24 | $0.36 | $1.31 | ||
| Q3 24 | $0.74 | $2.21 | ||
| Q2 24 | $0.85 | $2.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $341.0M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $2.1B |
| Total Assets | $5.5B | $3.0B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $341.0M | ||
| Q4 25 | $133.2M | $384.1M | ||
| Q3 25 | $118.7M | $297.3M | ||
| Q2 25 | $131.4M | $190.4M | ||
| Q1 25 | $91.2M | $150.3M | ||
| Q4 24 | $76.3M | $239.4M | ||
| Q3 24 | $82.1M | $339.4M | ||
| Q2 24 | $77.2M | $354.9M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $300.0M | ||
| Q3 25 | $2.3B | $371.3M | ||
| Q2 25 | $2.3B | $376.9M | ||
| Q1 25 | $2.2B | $382.5M | ||
| Q4 24 | $2.0B | $388.1M | ||
| Q3 24 | $1.9B | $393.8M | ||
| Q2 24 | $1.8B | $399.4M |
| Q1 26 | $2.0B | $2.1B | ||
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $1.9B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.0B | $1.9B | ||
| Q2 24 | $3.0B | $1.8B |
| Q1 26 | $5.5B | $3.0B | ||
| Q4 25 | $5.5B | $3.1B | ||
| Q3 25 | $6.4B | $3.0B | ||
| Q2 25 | $6.3B | $3.0B | ||
| Q1 25 | $6.1B | $2.8B | ||
| Q4 24 | $6.0B | $2.7B | ||
| Q3 24 | $5.9B | $2.9B | ||
| Q2 24 | $5.7B | $2.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.15× | ||
| Q3 25 | 0.74× | 0.19× | ||
| Q2 25 | 0.74× | 0.20× | ||
| Q1 25 | 0.72× | 0.21× | ||
| Q4 24 | 0.64× | 0.21× | ||
| Q3 24 | 0.62× | 0.21× | ||
| Q2 24 | 0.62× | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $155.7M | ||
| Q3 25 | $73.2M | $170.2M | ||
| Q2 25 | $133.5M | $125.2M | ||
| Q1 25 | $11.5M | $7.6M | ||
| Q4 24 | $116.7M | $115.8M | ||
| Q3 24 | $163.1M | $103.3M | ||
| Q2 24 | $171.1M | $111.1M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $119.0M | ||
| Q3 25 | $-63.0M | $133.9M | ||
| Q2 25 | $-34.2M | $87.3M | ||
| Q1 25 | $-163.2M | $-42.6M | ||
| Q4 24 | $-86.8M | $60.3M | ||
| Q3 24 | $-27.1M | $58.1M | ||
| Q2 24 | $16.9M | $70.9M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 22.1% | ||
| Q3 25 | -7.4% | 21.5% | ||
| Q2 25 | -3.9% | 13.8% | ||
| Q1 25 | -21.2% | -7.9% | ||
| Q4 24 | -11.2% | 11.7% | ||
| Q3 24 | -3.3% | 9.9% | ||
| Q2 24 | 2.1% | 11.9% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 6.8% | ||
| Q3 25 | 16.0% | 5.8% | ||
| Q2 25 | 19.3% | 6.0% | ||
| Q1 25 | 22.7% | 9.3% | ||
| Q4 24 | 26.3% | 10.7% | ||
| Q3 24 | 23.3% | 7.7% | ||
| Q2 24 | 19.4% | 6.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 2.77× | ||
| Q3 25 | 2.02× | 1.58× | ||
| Q2 25 | 4.43× | 1.21× | ||
| Q1 25 | 1.37× | 0.10× | ||
| Q4 24 | 3.58× | 2.09× | ||
| Q3 24 | 2.39× | 1.10× | ||
| Q2 24 | 2.18× | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
SSD
Segment breakdown not available.
